Related Experiment Video
Updated: Jan 29, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
Thymidylate synthase maintains the de-differentiated state of triple negative breast cancers
Aarif Siddiqui1, Paradesi Naidu Gollavilli1,2, Annemarie Schwab1
1Junior Research Group 1, IZKF, FAU Erlangen-Nürnberg, Erlangen, Germany.
Abstract:
Cancer cells frequently boost nucleotide metabolism (NM) to support their increased proliferation, but the consequences of elevated NM on tumor de-differentiation are mostly unexplored. Here, we identified a role for thymidylate synthase (TS), a NM enzyme and established drug target, in cancer cell de-differentiation and investigated its clinical significance in breast cancer (BC). In vitro, TS knockdown increased the population of CD24+ differentiated cells, and attenuated migration and sphere-formation. RNA-seq profiling indicated repression of epithelial-to-mesenchymal transition (EMT) signature genes upon TS knockdown, and TS-deficient cells showed an increased ability to invade and metastasize in vivo, consistent with the occurrence of a partial EMT phenotype. Mechanistically, TS enzymatic activity was found essential for maintenance of the EMT/stem-like state by fueling a dihydropyrimidine dehydrogenase-dependent pyrimidine catabolism. In patient tissues, TS levels were found significantly higher in poorly differentiated and in triple negative BC, and strongly correlated with worse prognosis. The present study provides the rationale to study in-depth the role of NM at the crossroads of proliferation and differentiation, and depicts new avenues for the design of novel drug combinations for the treatment of BC.
Insights
Thymidylate synthase (TS) drives cancer cell de-differentiation and metastasis by boosting nucleotide metabolism. Targeting TS may offer new strategies for treating aggressive breast cancer (BC).
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metabolism
Background:
- Cancer cells often upregulate nucleotide metabolism (NM) to support proliferation.
- The impact of elevated NM on tumor de-differentiation remains largely unknown.
Purpose of the Study:
- Investigate the role of thymidylate synthase (TS), an NM enzyme, in cancer cell de-differentiation.
- Explore the clinical significance of TS in breast cancer (BC).
Main Methods:
- In vitro TS knockdown experiments in cancer cells.
- RNA-sequencing (RNA-seq) for gene expression profiling.
- In vivo metastasis assays.
- Analysis of TS levels in patient breast cancer tissues.
Main Results:
- TS knockdown promoted cell differentiation and reduced migration and sphere formation.
- TS knockdown repressed epithelial-to-mesenchymal transition (EMT) signature genes.
- TS deficiency led to increased invasion and metastasis in vivo, suggesting a partial EMT phenotype.
- TS enzymatic activity fuels pyrimidine catabolism, maintaining the EMT/stem-like state.
- Elevated TS levels in poorly differentiated and triple-negative BC correlate with worse prognosis.
Conclusions:
- TS plays a critical role in cancer cell de-differentiation and metastasis.
- TS is a potential therapeutic target for aggressive breast cancer.
- Further research into NM's role in proliferation and differentiation is warranted for novel drug combinations.
Related Concept Videos
ATP Synthase: Structure
ATP Synthase: Mechanism
Scalar and Vector Triple Products
The scalar triple product is the dot product of a vector with the cross product of two vectors....
Negative Regulator Molecules
Positive, Negative, and Zero Work
Design Example: Maintaining Level of an Embankment

